In the treatment of cardiovascular disease, there is provided a use of a functional thylakoid extract, particularly in pharmaceutical use in admixture with a physiologically acceptable carrier, and a method for its treatment. Cardiovascular disease (CVD) can include several diseases associated with inflammation of the heart or arteries, including coronary artery disease (CAD), such as angina and myocardial infarction (commonly known as heart attack), atheroma Can include atherosclerosis, stroke, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, cardiac arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysm, peripheral arterial disease and venous thrombosis.心血管疾患の治療における、機能性チラコイド抽出物の、詳細には生理的に許容可能な担体と混合しての医薬用途での使用及びその治療方法が提供される。心血管疾患（ＣＶＤ）は、心臓又は動脈の炎症と関連するいくつかの疾患を含み得、冠状動脈疾患（ＣＡＤ）、例えば狭心症及び心筋梗塞（一般に心臓発作として知られている）、アテローム性動脈硬化症、卒中、高血圧性心疾患、リウマチ性心疾患、心筋症、心臓不整脈、先天性心疾患、弁膜性心疾患、心臓炎、大動脈瘤、末梢動脈疾患及び静脈血栓症を含み得る。
